In the occurrence and progression of tumors, the reason for tumor resistance to chemotherapeutic agents, which exert anti-tumor effects through p53, is that miR-34a is deactivated by the methylation of CpG islands (Kim and Kim, 2014; Qian et al., 2014). This evidence concerns the gene TP53 and neoplasm.